| ||
Retail trade in Tamil Nadu opposed to allowing FDI in pharmaceutical business pharmabiz.com The Tamil Nadu Chemists and Druggists Association (TNCDA), the body representing retail pharmaceutical traders in the state, has strongly objected to the proposed introduction of foreign direct investment (FDI) on the pharmaceutical retail business sector. See all stories on this topic » | ||
Research and Markets: International Directory of Pharmaceutical Companies ... PR Web (press release) International directory containing 20,000 pharmaceutical companies in 200+ countries and 30,000 executives working in the industry around the world. This powerful Directory is connection to key decision-makers in the pharmaceutical industry in Europe, ... See all stories on this topic » | ||
Reumofan voluntarily recalls all lots of Reumofan Plus Tablets Pharmaceutical Business Review US-based natural supplements firms Reumofan Plus USA and Reumofan USA has announced the voluntary recall of Reumofan Plus Tablets, as they contain undeclared active pharmaceutical ingredients: methocarbamol, dexamethasone, and diclofenac. See all stories on this topic » | ||
Study finds "Big Pharma" fails at self-policing ED drug advertising The Pharma Letter The pharmaceutical industry's efforts to self-regulate its direct-to-consumer (DTC) advertising are "an industry-sponsored ruse," intended to deflect criticism and collectively block new federal regulation, a study released in the Journal of Health ... See all stories on this topic » | ||
Drugmakers to continue facing growing generic competition in 2013 The Pharma Letter Generic competition is a major concern for large pharmaceutical companies as well as biotechnology firms. Earlier this month, Merck & Co. had reported a 7% drop in its fourth quarter profit due to hits from generic competition (The Pharma Letter ... See all stories on this topic » | ||
Global Pharma may leave Russian market due to protectionist policies The Pharma Letter The planned imposition of restrictions for the public purchase of imported drugs, initiated by the Russian government, may result in the departure of foreign pharmaceutical companies from the Russian market, local analysts and representatives of ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
1 comments:
We do consultancy service for FDA License and FDA compliance and Regulatory etc , Our consultancy network of Mumbai, Thane , Navimumbai etc for more details contact 9930962213
Post a Comment